Literature DB >> 12910307

Antioxidant status of rats receiving lycopene in different doses.

L V Kravchenko1, S V Morozov, N A Beketova, V P Deryagina, L I Avren'eva, V A Tutel'yan.   

Abstract

Oral treatment with lycopene (per os) in doses of 10 or 50 mg/kg for 2 weeks led to accumulation of lycopene in the liver, liver microsomes, and blood plasma, increased total plasma antioxidant activity, inhibited LPO in the liver, and decreased solubilization of lysosomal enzymes. Lycopene had no effect on ex vivo resistance of liver microsomes to LPO and activities of antioxidant enzymes in the liver.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12910307     DOI: 10.1023/a:1024608730471

Source DB:  PubMed          Journal:  Bull Exp Biol Med        ISSN: 0007-4888            Impact factor:   0.804


  2 in total

1.  Lycopene prevents development of steatohepatitis in experimental nonalcoholic steatohepatitis model induced by high-fat diet.

Authors:  Ibrahim Halil Bahcecioglu; Nalan Kuzu; Kerem Metin; Ibrahim Hanifi Ozercan; Bilal Ustündag; Kazim Sahin; Omer Kucuk
Journal:  Vet Med Int       Date:  2010-10-03

2.  Lycopene supplementation suppresses oxidative stress induced by a high fat diet in gerbils.

Authors:  Soo-Kyong Choi; Jung-Sook Seo
Journal:  Nutr Res Pract       Date:  2013-02-04       Impact factor: 1.926

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.